PL2185203T3 - Utleniona awidyna o długim czasie przebywania w leczonych tkankach - Google Patents

Utleniona awidyna o długim czasie przebywania w leczonych tkankach

Info

Publication number
PL2185203T3
PL2185203T3 PL08775109T PL08775109T PL2185203T3 PL 2185203 T3 PL2185203 T3 PL 2185203T3 PL 08775109 T PL08775109 T PL 08775109T PL 08775109 T PL08775109 T PL 08775109T PL 2185203 T3 PL2185203 T3 PL 2185203T3
Authority
PL
Poland
Prior art keywords
residency time
treated tissues
oxidized avidin
high residency
avidin
Prior art date
Application number
PL08775109T
Other languages
English (en)
Inventor
Santis Rita De
Carlo Antonio Nuzzolo
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL2185203T3 publication Critical patent/PL2185203T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08775109T 2007-08-02 2008-07-16 Utleniona awidyna o długim czasie przebywania w leczonych tkankach PL2185203T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07113733 2007-08-02
EP08157473 2008-06-03
EP08775109.5A EP2185203B1 (en) 2007-08-02 2008-07-16 Oxidized avidin with high residency time in the treated tissues

Publications (1)

Publication Number Publication Date
PL2185203T3 true PL2185203T3 (pl) 2017-08-31

Family

ID=39734214

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08775109T PL2185203T3 (pl) 2007-08-02 2008-07-16 Utleniona awidyna o długim czasie przebywania w leczonych tkankach

Country Status (26)

Country Link
US (1) US8562947B2 (pl)
EP (1) EP2185203B1 (pl)
JP (1) JP5577248B2 (pl)
KR (1) KR101544628B1 (pl)
CN (1) CN101772353B (pl)
AR (1) AR067771A1 (pl)
AU (1) AU2008281901B2 (pl)
BR (1) BRPI0815050B8 (pl)
CA (1) CA2694391C (pl)
DK (1) DK2185203T3 (pl)
EA (1) EA017017B1 (pl)
ES (1) ES2625815T3 (pl)
HK (1) HK1145290A1 (pl)
HR (1) HRP20170735T1 (pl)
HU (1) HUE032093T2 (pl)
IL (1) IL203321A (pl)
LT (1) LT2185203T (pl)
MX (1) MX2010001302A (pl)
MY (1) MY155347A (pl)
NZ (1) NZ582711A (pl)
PL (1) PL2185203T3 (pl)
PT (1) PT2185203T (pl)
SG (1) SG183076A1 (pl)
SI (1) SI2185203T1 (pl)
TW (1) TWI441650B (pl)
WO (1) WO2009016031A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2591524C2 (ru) * 2010-12-28 2016-07-20 Джапан Тобакко Инк. Модифицированный тамавидин
ES2729549T3 (es) 2011-08-02 2019-11-04 Alfasigma Spa Composición farmacéutica de avidina oxidada adecuada para la inhalación
JP2014001204A (ja) * 2012-05-23 2014-01-09 Kumamoto Univ 腫瘍細胞選択的抗がん剤
JP2016511747A (ja) 2013-01-04 2016-04-21 マサチューセッツ インスティテュート オブ テクノロジー ナノ粒子表面結合に基づく薬物の組織への送達
EP3316871A4 (en) 2015-06-30 2019-02-20 The Trustees of Columbia University in the City of New York TALKED COMPOSITION AND USES THEREOF
US20200179530A1 (en) * 2016-05-19 2020-06-11 University Of Miami Targeted delivery of therapeutic agents and imaging reagents to pancreatic cancer cells
CN112703401A (zh) * 2018-09-25 2021-04-23 美国西门子医学诊断股份有限公司 用于从使用缀合的分子阱的测定除去生物素干扰的方法和组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433343D1 (de) * 1993-12-07 2003-12-24 Neorx Corp Pretargeting verfahren und mitteln
US5716594A (en) * 1994-06-06 1998-02-10 The Jmde Trust Biotin compounds for targetting tumors and sites of infection
US8021667B2 (en) * 1994-11-16 2011-09-20 Macfarlane Burnet Institute For Medical Research And Public Health Ltd Compositions for immunotherapy and uses thereof
US6632929B1 (en) * 1998-11-10 2003-10-14 Yeda Research And Development Co. Ltd Avidin derivatives and uses thereof
US7001994B2 (en) * 2001-01-18 2006-02-21 Genzyme Corporation Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
US20040101901A1 (en) * 2002-11-27 2004-05-27 Piotr Tabaczewski Novel lipophilic complexes for insertion of receptors into lipid membranes
ITRM20030196A1 (it) * 2003-04-24 2004-10-25 Sigma Tau Ind Farmaceuti Uso di reagenti per la preparazione di un medicamento

Also Published As

Publication number Publication date
AR067771A1 (es) 2009-10-21
IL203321A (en) 2014-05-28
KR20100051696A (ko) 2010-05-17
EA017017B1 (ru) 2012-09-28
HUE032093T2 (en) 2017-08-28
JP2010535166A (ja) 2010-11-18
CN101772353A (zh) 2010-07-07
EA201070216A1 (ru) 2010-08-30
TWI441650B (zh) 2014-06-21
JP5577248B2 (ja) 2014-08-20
AU2008281901B2 (en) 2013-08-15
US8562947B2 (en) 2013-10-22
CA2694391C (en) 2019-02-26
SG183076A1 (en) 2012-08-30
HRP20170735T1 (hr) 2017-07-28
BRPI0815050B1 (pt) 2020-01-28
PT2185203T (pt) 2017-06-02
KR101544628B1 (ko) 2015-08-17
HK1145290A1 (en) 2011-04-15
CA2694391A1 (en) 2009-02-05
US20100239497A1 (en) 2010-09-23
EP2185203B1 (en) 2017-02-22
AU2008281901A1 (en) 2009-02-05
NZ582711A (en) 2011-10-28
TW200920403A (en) 2009-05-16
CN101772353B (zh) 2013-03-06
ES2625815T3 (es) 2017-07-20
BRPI0815050B8 (pt) 2021-05-25
LT2185203T (lt) 2017-06-12
DK2185203T3 (da) 2017-06-06
MY155347A (en) 2015-10-15
BRPI0815050A2 (pt) 2015-02-10
MX2010001302A (es) 2010-03-01
EP2185203A1 (en) 2010-05-19
WO2009016031A1 (en) 2009-02-05
BRPI0815050A8 (pt) 2017-12-26
SI2185203T1 (sl) 2017-07-31

Similar Documents

Publication Publication Date Title
ZA201001145B (en) Improvements in lavatory treatment devices
EP1957413A4 (en) WASTE WATER TREATMENT
IL206819A0 (en) Pyrrolopyrimidines and pyrrolopyridines
GB0506759D0 (en) Combination treatment methods
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
SI2185203T1 (sl) Oksidiran avidin z visokim zadrževalnim časom v obdelanih tkivih
GB0516254D0 (en) Improvements in devices
GB0621527D0 (en) Acne treatment
GB0515138D0 (en) Acne treatment
EP2142753A4 (en) TREATMENT AND REUSE OF DRILLING
GB0525540D0 (en) New treatment
GB0701728D0 (en) Assays and therapy
GB0619344D0 (en) Safe reversing
GB2431198B (en) Improvements in locks
GB0513680D0 (en) Biowaste treatment
GB2459892B (en) The hand and object casting technique and the kit
GB0601125D0 (en) Improvements in artificial lift mechanisms
EG24874A (en) Integrated power saver
GB0713531D0 (en) Improvements in artificial lift mechanisms
PL372542A1 (pl) Zespół do recyrkulacji ścieków
GB0520407D0 (en) Improvements in hydrodynamic control
GB0520424D0 (en) Improvements in hydrodynamic control
GB0622452D0 (en) Improvements in propellers
GB0624505D0 (en) Power saver
TWM301259U (en) Lockset with removable rack